These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26826702)

  • 1. A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.
    Cunningham FE; Hur K; Dong D; Miller DR; Zhang R; Wei X; McCarren M; Mosholder AD; Graham DJ; Aspinall SL; Good CB
    Addiction; 2016 Jul; 111(7):1283-92. PubMed ID: 26826702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
    Meyer TE; Taylor LG; Xie S; Graham DJ; Mosholder AD; Williams JR; Moeny D; Ouellet-Hellstrom RP; Coster TS
    Addiction; 2013 Jan; 108(1):203-10. PubMed ID: 22812921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
    Carney G; Bassett K; Maclure M; Taylor S; Dormuth CR
    Addiction; 2020 Aug; 115(8):1534-1546. PubMed ID: 32077187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of varenicline versus bupropion and risk of psychiatric adverse events.
    Pasternak B; Svanström H; Hviid A
    Addiction; 2013 Jul; 108(7):1336-43. PubMed ID: 23445269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.
    Shah D; Shah A; Tan X; Sambamoorthi U
    Drug Alcohol Depend; 2017 Aug; 177():187-193. PubMed ID: 28605678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world effectiveness of varenicline versus nicotine replacement therapy in patients with and without psychiatric disorders.
    Kaduri P; Voci S; Zawertailo L; Chaiton M; McKenzie K; Selby P
    J Addict Med; 2015; 9(3):169-76. PubMed ID: 25622124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.
    Wu Q; Gilbody S; Peckham E; Brabyn S; Parrott S
    Addiction; 2016 Sep; 111(9):1554-67. PubMed ID: 27043328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline.
    Garcia-Portilla MP; Garcia-Alvarez L; Sarramea F; Galvan G; Diaz-Mesa E; Bobes-Bascaran T; Al-Halabi S; Elizagarate E; Iglesias C; Saiz Martínez PA; Bobes J
    Schizophr Res; 2016 Oct; 176(2-3):272-280. PubMed ID: 27237598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings.
    Gerlach LB; Van T; Kim HM; Chang MM; Bohnert KM; Zivin K
    J Clin Psychiatry; 2021 Dec; 83(1):. PubMed ID: 34936245
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
    Lerman C; Schnoll RA; Hawk LW; Cinciripini P; George TP; Wileyto EP; Swan GE; Benowitz NL; Heitjan DF; Tyndale RF;
    Lancet Respir Med; 2015 Feb; 3(2):131-138. PubMed ID: 25588294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
    Shewale AR; Borse MS; Brown JD; Li C
    Drug Alcohol Depend; 2015 Sep; 154():132-8. PubMed ID: 26169448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
    Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
    Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study.
    Molero Y; Lichtenstein P; Zetterqvist J; Gumpert CH; Fazel S
    BMJ; 2015 Jun; 350():h2388. PubMed ID: 26037950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effectiveness of varenicline and transdermal nicotine patch in outpatients following a standardized smoking cessation program in Southern Taiwan.
    Hsueh SC; Hsueh KC; Chou MY; Tu MS
    Eval Health Prof; 2015 Mar; 38(1):115-25. PubMed ID: 23221355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.
    Gershon AS; Campitelli MA; Hawken S; Victor C; Sproule BA; Kurdyak P; Selby P
    Am J Respir Crit Care Med; 2018 Apr; 197(7):913-922. PubMed ID: 29260881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
    Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
    Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.